About: The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 1997 (uk) im November 1997 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 November 1997 (en) artículu científicu espublizáu en payares de 1997 (ast)
publication date	wds:Q73865753-10359B70-C932-4387-BA86-CEE541C778D0
publication date	1997-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73865753-49636537-4605-4278-A757-E3C92B8A4BA1
language of work or name	English
cites work	wds:Q73865753-02A23DA8-57E4-4D81-BEC2-8C064ACAA1E2 wds:Q73865753-061E0CA3-2CC9-4E52-A7D6-277D5E69E733 wds:Q73865753-110F5538-F049-49E1-B64A-FFE2C0CF0E57 wds:Q73865753-186D7414-1933-40C1-B3C0-B434B54BEFF5 wds:Q73865753-3688151E-C9D8-42A8-AD59-D1E403D614D2 wds:Q73865753-3717F108-BDDF-4D31-8EB3-BB95F8FE3E46 wds:Q73865753-3C14E09C-AD2D-435A-BE38-04548B3D04E3 wds:Q73865753-44F79DF9-0014-4E71-91E0-622CA27A3B3F wds:Q73865753-4DD74804-5E39-43E8-BED2-14E9FA94422D wds:Q73865753-4FCBD7AB-FA21-440F-8FA5-5F9D11F50C5C wds:Q73865753-5AA62BA2-776A-4E22-A2F2-7D134358F31D wds:Q73865753-5E48C38F-1506-4E3B-A3DA-EC459040C8E4 wds:Q73865753-5F86E6E9-6D2B-41F5-AC3C-E43D6088750C wds:Q73865753-844DF0C5-0210-4273-B445-7F7205B637D1 wds:Q73865753-852BE240-3F63-4B75-AA61-5A3DEECDDBB7 wds:Q73865753-90310C55-ABB5-42CE-8979-EB51F12238A4 wds:Q73865753-91C74139-7544-447C-9EDA-C7DF83DDF5B2 wds:Q73865753-99571504-CB56-4FC0-8AEC-872E911D7DA5 wds:Q73865753-A1C191D4-256F-470E-9C14-A76E63BBA13A wds:Q73865753-A92F70EF-1A23-45CB-9E54-3C3ADAF9A389 wds:Q73865753-CBB85441-0005-48E1-86C9-1EF3AEDDC4CB wds:Q73865753-DAAEDF3A-4554-4A95-A8C7-7B4CF0EDAF63 wds:Q73865753-E44615A5-7C9F-449A-801C-24EE4C6F5D14 wds:Q73865753-FB849903-FE5F-4C9D-B658-9BF1BF251A41
cites work	Both immunization with protein and recombinant vaccinia virus can stimulate CTL specific for the E7 protein of human papilloma virus 16 in H-2d mice. Clinical and immunologic responses to human immunodeficiency virus (HIV) type 1SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteers A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected] MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Different Protection Rates in Various Groups of Volunteers Given Subunit Influenza Virus Vaccine in 1976 Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly Medical practice-based influenza surveillance: viral prevalence and assessment of morbidity MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice Comparative trial of influenza vaccines. II. Adverse reactions in children and adults A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59. Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths Influenza virus ISCOMs: antibody response in animals In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant Phase 1 clinical tests of influenza MDP-virosome vaccine (KD-5382). Influenza epidemic among a community of elderly people in spite of vaccination Long-Term Studies of Microencapsulated and Adsorbed Influenza Vaccine Nanoparticles Immune response and protection against influenza A infection in mice immunised with subunit influenza A vaccine in combination with whole cell or acellular DTP vaccine Influenza virus pyrogenicity: central role of structural orientation of virion components and involvement of viral lipid and glycoproteins
author name string	wds:Q73865753-8FF56B26-4AAC-461B-9643-6ECD687C6F7A wds:Q73865753-D19B9BD0-7977-456C-99CD-BC1800F955A4
author name string	G Van Nest D M Cataldo
rdfs:label	The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice (en) The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice (nl)
skos:prefLabel	The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice (en) The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice (nl)
name	The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice (en) The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice (nl)
title	wds:Q73865753-7B9A7EF4-1C2A-4FBF-BED8-02D786E27877
title	The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice (en)
page(s)	wds:Q73865753-4FB0EC00-6A3D-4FE6-A04A-8E062FE4EB6E
page(s)	1710-1715
instance of	wds:Q73865753-4B37C221-CC8A-486B-890F-BBF5844181D0
instance of	scholarly article
main subject	wds:Q73865753-4857EFCE-6FE5-4242-9914-79E05E75BC06 wds:Q73865753-DA133004-6CB0-4C7D-8590-8C9550C24BE9
main subject	immunologic adjuvant influenza vaccine
PubMed ID	wds:Q73865753-94BABDBB-15F7-4C6F-B8C0-101DC06D7CDA
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9364672
PubMed ID	9364672
published in	wds:Q73865753-EFACF552-C474-42ED-AD63-88CF55D3B4FC
published in	Vaccine
issue	wds:Q73865753-85EC6695-32A2-43F3-84CE-ED7A08A0EDE7
volume	wds:Q73865753-85E5283C-049E-4AAE-BAF7-46ADFE9764AF
issue	16
volume	15
DOI	wds:Q73865753-ECAE4309-541E-4A72-ADD2-5632FDEB61FC
DOI	http://dx.doi.org/10.1016/S0264-410X(97)00115-1
DOI	10.1016/S0264-410X(97)00115-1
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73865753
is cites work of	Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine. MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis Recent developments in adjuvants for vaccines against infectious diseases Preclinical evaluation of the saponin derivative GPI-0100 as an immunostimulating and dose-sparing adjuvant for pandemic influenza vaccines MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development? Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants. Recent advances in vaccine adjuvants Advances in vaccine adjuvants Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software